Immuneering Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results. Needham Reiterated a Buy Rating on the Stock.
Immuneering Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results. Needham Reiterated a Buy Rating on the Stock.
Immuneering的股票在公司公佈超出預期的第三季度每股收益後上漲。Needham重申了對該股的買入評級。
Immuneering Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results. Needham Reiterated a Buy Rating on the Stock.
Immuneering 股份在公司報告了超出預期的第三季度每股收益後上漲。Needham 重申了對該股票的買入評級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間